Funding for this research was provided by:
Prostate Cancer Foundation of Australia
Text and Data Mining valid from 2019-09-05
Received: 17 April 2019
Accepted: 16 August 2019
First Online: 5 September 2019
Ethics approval and consent to participate
: This prospective interventional clinical trial was approved by the Peter MacCallum Cancer Centre institutional review board, Melbourne, Australia (POPSTAR, ‘Pilot Study of patients with Oligometastases from Prostate cancer treated with STereotactic Ablative Radiotherapy’, Universal Trial Number U1111–1140-7563). All patients signed informed consent.
: Not applicable.
: The authors declare that they have no competing interests.